What Are the Uses of Buprenorphine and Naloxone?
The clinical use of compound buprenorphine and naloxone preparations is relatively complicated. In order to solve various technical problems, Professor Hao Wei from the Institute of Mental Health of the Second Xiangya Hospital of Central South University organized a group of long-term clinical detoxification work, who has hosted or participated in Compound buprenorphin naloxone preparations have been used in phase III clinical trials in China, and psychiatrists with rich theoretical knowledge and clinical experience have prepared this guide. The guideline of this guideline is the knowledge of detoxification theory and related knowledge and skills of buprenorphin and naloxone preparations in hospitals, including opioid clinical pharmacology, patient evaluation, treatment plan, and treatment of special patients. 2. Treatment of poisoning of compound buprenorphine naloxone preparations. The Guidelines for the Clinical Use of Compound Buprenorphin Naloxone Preparations are based on practicality and evidence-based. It is suitable for professionals in mental health, detoxification institutions and staff engaged in opioid dependence maintenance treatment.
Guidelines for clinical use of compound buprenorphin naloxone preparations
- Chinese name
- Guidelines for clinical use of compound buprenorphin naloxone preparations
- Publishing house
- Science Press
- Pages
- 177 pages
- Open
- 5
- Author
- Hao Wei
- Publication date
- June 1, 2014
- Language
- Simplified Chinese
- ISBN
- 7030408047
- The clinical use of compound buprenorphine and naloxone preparations is relatively complicated. In order to solve various technical problems, Professor Hao Wei from the Institute of Mental Health of the Second Xiangya Hospital of Central South University organized a group of long-term clinical detoxification work, who has hosted or participated in Compound buprenorphin naloxone preparations have been used in phase III clinical trials in China, and psychiatrists with rich theoretical knowledge and clinical experience have prepared this guide. The guideline of this guideline is the knowledge of detoxification theory and related knowledge and skills of buprenorphin and naloxone preparations in hospitals, including opioid clinical pharmacology, patient evaluation, treatment plan, and treatment of special patients. 2. Treatment of poisoning of compound buprenorphine naloxone preparations. The Guidelines for the Clinical Use of Compound Buprenorphin Naloxone Preparations are based on practicality and evidence-based. It is suitable for professionals in mental health, detoxification institutions and staff engaged in opioid dependence maintenance treatment.
- Chapter 1 outlines the current status of the use of opioid receptor agonists in the treatment of opioid dependence. Section 2 The purpose of compiling guidelines for clinical use. Chapter 2. Related concepts of substance dependence. Concepts Section 2 Clinical Pharmacology of Buprenorphine Section 3 Clinical Pharmacology of Naloxone Section 4 Clinical Pharmacology of Compound Buprenorphine Naloxone Preparations Section 5 Summary Chapter 4 Patient Evaluation Section 1 Screening and evaluation of patients with opioid dependence Section 2 Diagnosis of opioid dependence Section 3 Pre-maintenance assessment of compound buprenorphin naloxone preparations Section 4 Summary Chapter 5 Treatment options Section 1 Overview Section 2 Maintenance treatment plan of compound buprenorphine naloxone preparation Section 3 Compound buprenorphine naloxone preparation for detoxification of opioid dependence Section 4 Compound buprenorphine naloxone preparation for maintenance treatment Management Section 5 Summary Chapter 6 Treatment of Special Patients Section 1 Patients with physical diseases Section 2 Pregnant women and newborns Section 3 Adolescents and elderly patients Section 4 Patients with other mental disorders Section 4 Section 6 Patients with multi-substance abuse Section 6 Patients with pain disorders Section 7 Summary Chapter 7 Treatment of compound buprenorphine naloxone preparation poisoning Section 1 Acute poisoning Section 2 Summary Chapter 8 Guidelines Essentials Section 1 Basic concepts Section 2 Clinical Evaluation and Diagnosis Section 3 Therapeutic Reference Appendix Appendix 1 Psychoactive Substance Use Screening Scale Appendix 2 Alcohol Disorder Screening Scale Appendix 3 Clinical Opioid Withdrawal Symptom Scale Appendix 4 Desire Scale Appendix 5 ICD-10 diagnostic criteria for mental disorders related to substance abuse